Equine umbilical cord blood contains a population of stem cells that express Oct4 and differentiate into mesodermal and endodermal cell types

Journal of Cellular Physiology

Volumn 215, Issue 2, 2008, Pages 329-336

  Reed, Sarah A ^a   Johnson, Sally E ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; COLLAGEN TYPE 2; CYTOKERATIN 18; DESMIN; GLYCOSAMINOGLYCAN; HELICASE; OCTAMER TRANSCRIPTION FACTOR 4; OSTEONECTIN; PROTEOGLYCAN; REAGENT; STAGE SPECIFIC EMBRYO ANTIGEN 1; TRAI 60 PROTEIN; TRAI 81 PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL POPULATION; CELL TYPE; ENDODERM; FIBROBLAST; GENETIC TRANSCRIPTION; HORSE; HUMAN; HUMAN CELL; INJURY; LIVER CELL; MESODERM; MUSCLE CELL; NEWBORN; NONHUMAN; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; STEM CELL; UMBILICAL CORD BLOOD; ANIMAL; CARTILAGE CELL; CYTOLOGY; FETUS BLOOD; METABOLISM;

EQUIDAE;

ADIPOCYTES; ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; ENDODERM; FETAL BLOOD; HORSES; MESODERM; MUSCLE CELLS; OCTAMER TRANSCRIPTION FACTOR-3; OSTEOCYTES; STEM CELLS;

EID: 40949096438     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21312     Document Type: Article

References (48)

1. Aoki M, Yasutake M, Murohara T. 2004. Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell filtration device. Stem Cells (Dayton, Ohio) 22:994-1002.
2. Baal N, Reisinger K, Jahr H, Bohle RM, Liang O, Munstedt K, Rao CV. Preissner KT, Zygmunt MT. 2004. Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood. Thromb Haemost 92:767-775.
3. Battula VL, Bareiss PM, Treml S, Conrad S, Albert I, Hojak S, Abele H, Schewe B, Just L, Skutella T, Buhring HJ. 2007. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differ Res Biol Divers 75:279-291.
4. Bi W, Deng JM, Zhang Z, Behringer RR. de Crombrugghe B. 1999. Sox9 is required for cartilage formation. Nat Genet 22:85-89.
5. Bonanno G, Perillo A, Rutella S. De Ritis DG, Mariotti A, Marone M, Meoni F, Scambia G, Leone G, Mancuso S, Pierelli L. 2004. Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells. Transfusion 44:1087-1097.
6. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG. Gifford DK, Melton DA. Jaenisch R, Young RA. 2005. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947-956.
7. Carlin R, Davis D, Weiss M, Schultz B, Troyer D. 2006. Expression of early transcription factors Oct4, Sox2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod Biol Endocrinol 4:8.
8. Chan J, O'Donoghue K, Gavina M, Torrente Y, Kennea N, Mehmet H, Stewart H, Watt DJ, Morgan JE, Fisk NM. 2006. Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells (Dayton. Ohio) 24:1879-1891.
9. Feinberg AP. 2007. Phenotypic plasticity and the epigenetics of human disease. Nature 447:433-440.
10. Fortier LA, Nixon AJ, Williams J, Cable CS. 1998. Isolation and chondrocyte differentiation of equine bone marrow-derived mesenchymal stem cells. Am J Vet Res 59:1182-1187.
11. Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RC. 2007. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109:1743-1751.
12. Giordano A, Galderisi U, Marino IR. 2007. From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells. J Cell Physiol 211:27-35.
13. He X, Gonzalez V, Tsang A, Thompson J, Tsang TC, Harris DT. 2005. Differential gene expression profiling of CD34+ CD133+ umbilical cord blood hematopoietic stem progenitor cells. Stem Cells Dev 14:188-198.
14. Henderson JK, Draper JS, Baillie HS, Fishel S, Thomson JA, Moore H, Andrews PW. 2002. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells (Dayton, Ohio) 20:329-337.
15. Holm M, Kvistgaard H, Dahl C, Andersen HB, Hansen TK, Schiotz PO, Junker S. 2006. Modulation of chemokine gene expression in CD133+ cord blood-derived human mast cells by cyclosporin A and dexamethasone. Scand J Immunol 64:571-579.
16. Hong SH, Gang EJ, Jeong JA, Ahn C, Hwang SH, Yang IH, Park HK, Han H, Kim H. 2005. In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells. Biochem Biophys Res Commun 330:1153-1161.
17. Kadivar M, Khatami S, Mortazavi Y, Shokrgozar MA. Taghikhani M, Soleimani M. 2006. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem Biophys Res Commun 340:639-647.
18. Kang XQ, Zang WJ, Bao LJ, Li DL, Song TS, Xu XL, Yu XJ. 2005. Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes. World J Gastroenterol 11:7461-7465.
19. Koch TG, Heerkens T, Thomsen PD, Betts DH. 2007. Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnol 7:26.
20. Koerner J, Nesic D, Romero JD, Brehm W, Mainil-Varlet P, Grogan SP. 2006. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells. Stem Cells 24:1613-1619.
21. Kogler G, Sensken S, Wernet P. 2006. Comparative generation and characterization of pluripotent unrestricted somatic stem cells with mesenchymal stem cells from human cord blood. Exp Hematol 34:1589-1595.
22. Lee MW, Yang MS. Park JS, Kim HC, Kim YJ, Choi J. 2005. Isolation of mesenchymal stem cells from cryopreserved human umbilical cord blood. Int J Hematol 81:126-130.
23. Lefebvre V, Behringer RR, de Crombrugghe B. 2001. L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage 9:S69-S75.
24. Li X, Zhou SG, lmreh MP, Ahrlund-Richter L, Allen WR. 2006. Horse embryonic stem cell lines from the proliferation of inner cell mass cells. Stem Cells Dev 15:523-531.
25. Markov V, Kusumi K. Tadesse MG, William DA, Hall DM, Lounev V, Carlton A, Leonard J, Cohen RI, Rappaport EF, Saitta B. 2007. Identification of cord blood-derived mesenchymal stem/stromal cell populations with distinct growth kinetics, differentiation potentials, and gene expression profiles. Stem Cells Dev 16:53-73.
26. Martin-Rendon E, Hale SJ, Ryan D, Baban D, Forde SP, Roubelakis M, Sweeney D, Moukayed M, Harris AL, Davies K, Watt SM. 2007. Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in responseto hypoxia. Stem Cells (Dayton, Ohio) 25:1003-1012.
27. McGuckin CP, Pearce D, Forraz N, Tooze JA, Watt SM, Pettengell R. 2003. Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow. Eur J Haematol 71:341-350.
28. McGuckin CP, Forraz N, Baradez MO, Navran S, Zhao J, Urban R, Tilton R, Denner L. 2005. Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif 38:245-255.
29. Ng LJ, Wheatley S, Muscat GE, Conway-Campbell J, Bowles J, Wright E, Bell DM, Tam PP, Cheah KS, Koopman P. 1997. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol 183:108-121.
30. Nunes VA, Cavacana N, Canovas M, Strauss BE, Zatz M. 2007. Stem cells from umbilical cord blood differentiate into myotubes and express dystrophin in vitro only after exposure to in vivo muscle environment. Biol Cell 99:185-196.
31. Peled T, Mandel J, Goudsmid RN, Landor C, Hasson N, Harati D, Austin M, Hasson A, Fibach E, Shpall EJ, Nagler A. 2004. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy 6:344-355.
32. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. 2000. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat Biotechnol 18:399-404.
33. Ruzicka K, Grskovic B, Pavlovic V, Qujeq D, Karimi A, Mueller MM. 2004. Differentiation of human umbilical cord blood CD133+ stem cells towards myelo-monocytic lineage. Clin Chim Acta 343:85-92.
34. Saito S, Ugai H, Sawai K, Yamamoto Y, Minamihashi A, Kurosaka K, Kobayashi Y, Murata T, Obata Y, Yokoyama K. 2002. Isolation of embryonic stem-like cells from equine blastocysts and their differentiation in vitro. FEBS Lett 531:389-396.
35. Stenderup K, Justesen J, Clausen C, Kassem M. 2003. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33:919-926.
36. Stojkovic M, Lako M, Stojkovic P, Stewart R, Przyborski S, Armstrong L, Evans J, Herbert M, Hyslop L, Ahmad S, Murdoch A, Strachan T. 2004. Derivation of human embryonic stem cells from day-8 blastocysts recovered after three-step in vitro culture. Stem Cells (Dayton, Ohio) 22:790-797.
37. Sun B, Roh KH, Lee SR, Lee YS, Kang KS. 2007. Induction of human umbilical cord blood-derived stem cells with embryonic stem cell phenotypes into insulin producing islet-like structure. Biochem Biophys Res Commun 354:919-923.
38. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
39. Talens-Visconti R, Bonora A, Jover R, Mirabet V, Carbonell F, Castell JV, Gomez-Lechon MJ. 2006. Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. World J Gastroenterol 12:5834-5845.
40. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 1998. Embryonic stem cell lines derived from human blastocysts. Science (New York, NY) 282:1145-1147.
41. Tielens S, Verhasselt B, Liu J, Dhont M, Van Der Elst J, Cornelissen M. 2006. Generation of embryonic stem cell lines from mouse blastocysts developed in vivo and in vitro: Relation to Oct-4 expression. Reproduction (Cambridge, England) 132:59-66.
42. Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M, Mortier C, Bron D, Lagneaux L. 2005. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: Proliferation, Oct4 expression, and plasticity. Stem Cells 23:1105-1112.
43. Vidal MA, Kilroy GE, Johnson JR, Lopez MJ, Moore RM, Gimble JM. 2006. Cell growth characteristics and differentiation frequency of adherent equine bone marrow-derived mesenchymal stromal cells: Adipogenic and osteogenic capacity. Vet Surg 35:601-610.
44. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, Blake J, Schwager C, Eckstein V, Ansorge W, Ho AD. 2005. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33:1402-1416.
45. Wakitani S, Saito T, Caplan AI. 1995. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18:1417-1426.
46. Worster AA, Nixon AJ, Brower-Toland BD, Williams J. 2000. Effect of transforming growth factor beta1 on chondrogenic differentiation of cultured equine mesenchymal stem cells. Am J Vet Res 61:1003-1010.
47. Worster AA, Brower-Toland BD, Fortier LA, Bent SJ, Williams J, Nixon AJ. 2001. Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-beta 1 in monolayer and insulin-like growth factor-1 in a three-dimensional matrix. J Orthop Res 19:738-749.
48. Zhao Y, Wang H, Mazzone T. 2006. Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Exp Cell Res 312:2454-2464.